Woolfson Eye Institute
Clinical trials sponsored by Woolfson Eye Institute, explained in plain language.
-
New hope for down syndrome vision loss: corneal crosslinking trial launches
Disease control Recruiting nowThis study tests an experimental eye treatment called corneal crosslinking (CXL) for people with Down syndrome who have a condition that makes the front of the eye thin and misshapen, causing blurry vision. The treatment uses vitamin B2 drops and ultraviolet light to strengthen t…
Phase: PHASE3 • Sponsor: Woolfson Eye Institute • Aim: Disease control
Last updated May 13, 2026 16:02 UTC
-
Shorter UV light may be just as effective at halting corneal disease
Disease control Recruiting nowThis study tests a treatment called corneal crosslinking (CXL) for people with keratoconus and similar conditions that cause the cornea to thin and bulge, blurring vision. CXL uses vitamin B2 eye drops and UV light to strengthen the cornea and stop the disease from getting worse.…
Phase: PHASE3 • Sponsor: Woolfson Eye Institute • Aim: Disease control
Last updated May 07, 2026 18:40 UTC